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Summary 
Background: Few data is available concerning the associa-
tion between peripheral arterial disease (PAD) and red cell
distribution width (RDW). In this study, we analyzed the
relationship between RDW and atherosclerosis of the ves-
sels other than coronary arteries in patients who had under-
gone digital substraction angiography (DSA).
Methods: This study included 730 patients who had under-
gone DSA. Patients were divided into two groups according
to their angiographic images. The association between
RDW and atherosclerosis of peripheral arteries was analy-
zed. The relationship between atherosclerosis and smo-
king, hypertension (HT), diabetes mellitus (DM), hs-CRP,
hemoglobin, white blood cell (WBC), triglyceride, total cho-
lesterol, HDL and LDL cholesterol levels was assessed.
Results: Atherosclerosis was observed more common in
male and patients with older age, HT, DM and smoking
(p<0.001). hs-CRP and WBC levels were both in signifi-
cantly positive association with atherosclerosis (p<0.05).
However, there were no significant differences in the RDW
levels, hemoglobin, triglyceride, total cholesterol, LDL and
HDL cholesterol levels in the groups (p>0.05).
Conclusions: Our results seem to demonstrate that older
age, male gender, HT, DM and smoking are powerful risk
factors for PAD. In contrast to the previous reports, RDW
levels are found not to be associated with atherosclerosis of
peripheral arteries.
Keywords: red blood cell distribution width, peripheral
arterial disease, digital substraction angiography, athero -
sclerosis
Kratak sadr`aj
Uvod: Ima nekoliko podataka koji govore o vezi izme|u
peri fernog arterijskog oboljenja i raspona raspodele eritro -
cita (RDW). U ovom izu~avanju analiziran je odnos izme |u
RDW i ateroskleroze krvnih sudova osim koronarnih arte rija
u pacijenata koji su bili podvrgnuti digitalnoj angigrafiji
(DSA).
Metode: Ovo izu~avanje obuhvatilo je 730 pacijenata
pod vrgnutih DSA. Pacijenti su podeljeni u dve grupe prema
angigrafskoj slici.  Analizirana je veza izme|u RDW i atero -
skleroze perifernih arterija. Pra}ena je povezanost izme|u
ateroskleroze i pu{enja, hipertenzije (HT), diabetes melli-
tus-a (DM), hs-CRP, hemoglobina, leukocita (WBC), tri gli -
ce rida, ukupnog holesterola, i nivoa HDL i LDL holeste rola.
Rezultati: Ateroskleroza je bila ~e{}a kod mu{karaca i paci-
jenata starije dobi, sa HT, DM i pu{a~a (p<0,001). Nivoi
hs-CRP i WBC bili su u zna~ajnioj pozitivnoj korelacijhi sa
aterosklerozom (p<0,05). Me|utim, nije bilo zna~ajnih
razlika u nivoima RDW, hemoglobina, triglicerida, ukupnog
holesterola i nivoa LDL i HDL holesterola u grupama
(p>0,05).
Zaklju~ak: Rezultati ukazuju da su starije doba, mu{ki pol,
HT, DM i pu{enje zna~ajni faktori rizika za PAD. Nasuprot
ranijim istra`ivanjima, nije na|eno da su nivoi RDW pove -
zani sa aterosklerozom perifernih arterija.
Klju~ne re~i: {irina raspodele eritrocita, periferno arte -
rijsko oboljenje, digitalna angiografija, ateroskleroza
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Introduction
Red blood cell distribution width (RDW) reflects
the variation of red blood cell volume. It can easily be
measured by routine analysis of whole blood count
(1). Increased RDW results from heterogeneity of
erythrocyte size and erythrocyte fragmentation in the
circulation (2). Factors that cause increased eryth-
rocyte size heterogeneity include iron, vitamin B12
and folate deficiency, decreased erythrocyte life span
and impaired erythropoiesis. Increased RDW is also
related to oxidative stress and release of cytokine in
response to inflammation (3) RDW has been
demonstrated to be associated also with cardiovascu-
lar and pulmonary diseases (4). Several studies have
shown that high RDW is associated with coronary
artery atherosclerosis in hypertensive patients and
acute myocardial infarction (5, 6). 
Peripheral arterial disease (PAD) is associated
with increased mortality and morbidity (7). It is impor-
tant to identify factors that might contribute to such
high morbidity and mortality in PAD. Patients with PAD
show high levels of inflammation and oxidative stress,
which play roles in the progression of atherosclerotic
diseases (8). Whether RDW is predictive of  mortality
in patients with PAD is unknown. A recent study
demonstrated that  increased RDW is associated with
greater mortality in patients with PAD identified by
noninvasive lower-extremity arterial testing (9). Several
studies have been done to assess the relationship bet-
ween RDW and coronary artery atherosclerosis.
However, few data is available concerning the associa-
tion between PAD and RDW. In this study, we analyzed
the relationship between RDW and atherosclerosis of
the vessels other than coronary arteries in patients
who had undergone digital substraction angiography
(DSA). Our study is the first to use an invasive method,
DSA, for peripheral arterial evaluation. 
Methods
A total of 730 patients, who underwent DSA
(Artis Zee, Siemens Germany, and Integris V, Philips
Netherland) in our interventional radiology unit bet-
ween 2013 and 2014 were included in this study. All
patients provided written informed consent and the
local institutional ethics commitee approved the study
protocol. Patients had undergone aortography (n:92),
pelvic-iliac angiography (n:142), lower exremity angi-
ography (n:202), renal angiography (n:122), carotid
angiography (n:134) and upper extremity angiog-
raphy (n:38). We divided patients into two groups
according to their angiographic images. Patients who
had extensive stenosis and atherosclerosis or occlusi-
on were included in group 1. Patients with no stenosis
and atherosclerosis or who had normal findings were
included in group 2.
The patients’ demographic characteristics inclu-
ding age, sex and smoking status were acquired thro-
ugh a standardized questionnaire. The mean age of
the subjects in group 1 was 64.72±10.56 (427
males and 133 females), and the mean age of the
subjects in group 2 was 54.86 ± 13.96 (105 males
and 65 females). Smoking was defined as at least one
cigarette daily for 1 year. Hypertension (HT) was
defined as systolic blood pressure (SBP) 140 mmHg
and (or) diastolic (DBP) 90 mmHg or previous diag-
nosis of hypertension with use of antihypertensive
medication (10). Diabetes mellitus (DM) was defined
as a fasting blood glucose level 6.99 mmol/L, a ran-
dom glucose measurement >11.1 mmol/L or hemo-
globin A1c>0.065 proportion of total hemoglobin or
a previous diagnosis with any use of oral antidiabetic
agent and/or insulin (11). Exclusion criteria included
previous cardiovascular disease, the presence of
hemolytic, hepatic and renal diseases that could
affect white blood cells (WBC), red blood cells (RBC)
or hemoglobin. Patients who received erythrocyte
suspension for any reason within the past 6 months
were not considered for the study.
RDW, hemoglobin and WBC levels were meas-
ured using Abbott CELL-DYN 3700 automated CBC
analyzer. The normal reference range for RDW in our
laboratory is 11.6% to 15.5%. Serum total choles-
terol, LDL and HDL cholesterol, triglyceride and hs-
CRP levels were also determined.
Statistical analyses were performed with Stati -
stical Package for the Social Sciences software
(Version 9.0; SPSS, Inc., Chicago, IL). For continuous
variables, Kolmogorov-Smirnov test was applied to
test normal distribution. Mann-Whitney U test was
applied to compare ages, LDL cholesterol, triglyc-
eride, RDW, hemoglobin, WBC and hs-CRP levels
between two groups as the data was not distributed
normally. Independent samples t test was used to
compare total cholesterol and HDL cholesterol levels
because of normal distribution. The chi-square test
was used for comparison of categorical variables. For
continuous variables; numeric values are expressed as
mean±SD. A p value of <0.05 was considered statis-
tically.
Results
Aortography (thoracic or abdominal) was per-
formed in 92 patients. Although 26 of these patients
had no stenosis or occlusion, they had extensive ath-
erosclerosis. 15 patients had abdominal aortic steno-
sis. 18 patients had abdominal aortic occlusion. 59 of
these patients were included in group 1. 33 of these
patients were included in group 2.
Pelvic and iliac angiographies were performed in
142 patients. 20 patients had no atherosclerosis. 66
patients had stenosis. 56 patients had total occlusion.
We enrolled 122 of these patients in group 1 and 20
of these patients in group 2.
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Lower extremity angiography was performed in
202 patients. 138 patients had undergone femoral
angiography. Of the patients who had undergone
femoral angiography, 16 patients had no atheroscle-
rosis. 22 patients had stenosis. 100 patients had total
occlusion. 64 patients had undergone knee angiogra-
phy. Of the patients who had undergone knee angio -
graphy, 4 patients had no atherosclerosis. 8 patienst
had stenosis. 52 patients had total occlusion. We
enrolled 182 of these patients in group 1 and 20 of
these patients in group 2.
Renal angiography was performed in 122
patients. 49 patients had normal findings. 68 patients
had stenosis. 5 patients had total occlusion. So 73 of
these patients were enrolled in group 1 and 49 of
these patients in group 2.
Carotid angiography was performed in 134
patients. 27 patients had normal findings. 87 patients
had stenosis. 20 patients had total occlusion. 107 of
these patients were included in group 1 and 21 of
these patients in group 2.
Upper extremity angiography was performed in
38 patients. 21 patients had normal findings. 7
patients had stenosis. 10 patients had total occlusion.
17 of these patients were enrolled in group 1 and 21
of these patients in group 2.
The baseline characteristics are shown in Table
1. 190 patients had DM. 165 of these diabetic
patients were  in group 1 and 25 of these diabetic
patients were in group 2. A total of 558 patients had
HT. 464 of these patients were in group 1. 94 of
these hypertensive patients were in group 2. Number
of the patients who had smoked was 456. And 396
of these patients were in group 1, the others in group
2.
As shown in in Figure 1, the analysis of RDW val-
ues revealed no significant differences in any of the
groups (p=0.192). However, atherosclerosis was
observed more common in male patients compared
Table I Median and demographic levels of RDW and other parameters in each group.
Figure 1 Red Blood Cell Distribution Width.
Groups Group I(n=560)
Group II
(n=170) P value
Male/female 427/133 105/65 Chi-square=15,552;p<0.001
Age (y)* 64.72 ± 10.56 54.86 ± 13.96 Z=-8,712; p<0.001
Total cholesterol (mmol/L)* 4.83± 1.17 4.79± 1.49 t=-0.363; p=0.717
HDL cholesterol (mmol/L)* 1.0± 0.24 1.024 ±0.26 t=0.428; p=0.669
LDL cholesterol (mmol/L)* 2.99 ± 0.86 2.92 ± 0.84 Z=-0.449; p=0.652
Triglyceride (mmol/L)* 1.75 ± 0.95 1.66 ± 0.76 Z=-0,451; p=0.653
RDW* 16.15 ± 2.03 16.04 ± 2 Z=-1,306; p=0.192
HT +/- 464/96 94/76 Chi-square=58,557; p<0.001
DM +/- 165/395 25/145 Chi-square=12,332; p<0.001
Smoking +/- 396/164 60/110 Chi-square=72,546; p<0.001
Hemoglobin (g/L) 130.26 ± 20.14 130.45 ± 20.23 Z=-1,167; p=0.243
WBC count (×109/L) 9.06 ± 3.55 8.27 ± 2.77 Z=-1,167; p=0.003
hs-CRP (nmol/L) 312.76 ± 490.96 212.95 ± 277.91 Z=-1,971; p=0.049 
*Values are means ± standard deviation
*DM: Diabetes Mellitus; HDL: high-density lipoprotein; HT: hypertension; LDL: low-density lipoprotein; RDW: red blood cell dis-
tribution width; hs-CRP: high-sensitive C-reactive protein; WBC: white blood cell.
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to female patients (p<0.001). Patients with older age
had particularly extensive atherosclerosis in peripheral
arteries (p<0.001). Patients who had DM, HT and
smoking were more prone to atherosclerosis when
compared to the control group (p<0.001). And also,
hs-CRP and WBC levels were both in significantly
positive association with atherosclerosis (p<0.05).
But there were no significant differences in hemoglo-
bin, serum total cholesterol, LDL and HDL cholesterol
and triglyceride levels in these groups (p>0.05).
Discussion
The prevalence of PAD is increasing worldwide.
It is well known that the morbidity and mortality of
patients with PAD remain high despite current advan -
ces in revascularization techniques (12). Identification
of risk factors for atherosclerotic PAD will provide
insights into underlying pathophysiologic mecha-
nisms and facilitate the development of diagnostic
and therapeutic approaches.
PAD prevalence and incidence are age related.
With aging of the population, it seems likely that PAD
will increase in the future. And also, PAD seems to be
higher among men than men. In our study, athero-
sclerosis was observed more common in male
patients compared to female patients (p<0.001).
Patients with older age had particularly extensive ath-
erosclerosis in peripheral arteries (p<0.001). Our
result is in agreement with Criqui and associates, who
observed that PAD incidence rises >10% among
patients in their 60s and 70s (13). Smoking, HT and
DM are particularly strong risk factors for PAD. In our
study, patients with HT, DM and smoking had
increased atherosclerosis in peripheral arteries
(p<0.001). 
High levels of inflammation and oxidative stress
play roles in the progression of atherosclerosis in
PAD. hs-CRP is one of the most well-established bio-
markers of chronic inflammation. hs-CRP produced
by tissue macrophages and vascular smooth muscle
cells could appear in the atherosclerotic plaques (14).
Jia and associates showed that coronary artery athe-
rosclerotic patients have higher hs-CRP levels than
non coronary artery atherosclerotic patients (15). In
our study, hs-CRP and WBC levels were both in signi-
ficantly positive association with atherosclerosis in
peripheral arteries (p<0.05). Although the underlying
biological mechanisms remain unclear, RDW is also
assessed as a marker of chronic inflammation and
oxidative stress (3). Recent studies have demonstra-
ted that high RDW is associated with poor clinical out-
comes in patients with heart failure, coronary artery
disease, pulmonary hypertension and PAD (9, 16).
Inflammatory cytokine release in heart failure and
acute myocardial infarction might affect bone marrow
function and inhibit erythrocyte maturation induced
by erythropoietin. Therefore , RDW becomes elevated
(17). And also increased oxidative stress directly
damages erythrocytes and shortens their survival,
resulting in high RDW (18). According to Almer et al.
(19) coronary artery disease is significantly related
with inflammatory response of the vascular endothe-
lial injury, while RDW is involved in the process of
inflammation. Jia et al. (15) and associates demons-
trated that higher RDW levels were associated with
carotid artery stenosis and intimal medial thickness.
They assessed atherosclerosis and intimal medial
thickness via ultrasound. Also, Wen conducted a
study to demonstrate the relationship between RDW
and carotid artery atherosclerosis by using carotid ult-
rasonography (20). 
Recently, Ye and al. (9) and associates reported
a study which evaluated the utility of RDW to predict
mortality in patients with PAD. They used ankle-brac-
hial index which is an established noninvasive test for
peripheral arterial disease. They demonstrated that
higher RDW is associated with greater all-cause mor-
tality in patients with PAD identified in the noninvasive
vascular laboratory. And also, Zalawadiya et al. (21)
demonstrated a strong and independent relationship
between RDW and PAD. These findings are particu-
larly noteworthy as RDW appears to be an emerging
cost-effective biomarker. However, in our study, no
statistically significant difference was found between
two groups in terms of RDW levels. To date, RDW has
been evaluated in various clinical settings both in PAD
and other conditions before. However, this is the first
study to use an invasive method, DSA, for peripheral
arterial evaluation. DSA is stil considered the referen-
ce standard in vascular imaging (22). 
However, there are some limitations of our study
that have to be mentioned. Lack of data on serum
folate, vitamin B12 and iron levels exists in our study.
Therefore considering the data on the levels of serum
iron, folate and vitamin B12 should also be assessed.
And also, the patients are not examined for any mor-
bidity or mortality event. In this context, a longer peri-
od of prospective observation may provide more
prognostic information.
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